➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Mallinckrodt
Harvard Business School
Boehringer Ingelheim
Medtronic

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ETHINYL ESTRADIOL; LEVONORGESTREL

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for ETHINYL ESTRADIOL; LEVONORGESTREL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00117273 A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens Completed Duramed Research Phase 3 2005-06-01 This is a randomized, open-label study to evaluate pituitary ovarian suppression in healthy, reproductive-aged women using three different regimens of oral contraceptives (OCs). Two extended regimen OCs, Seasonale (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of placebo), and Seasonique (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 84 days followed by 7 days of ethinyl estradiol 0.01 mg), and a 28-day regimen OC, Portia (levonorgestrel/ethinyl estradiol 0.15/0.03 mg for 21 days followed by 7 days of placebo).
NCT00128934 Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 2005-08-01 The purpose of this study is to determine whether levonorgestrel (LNG)/ethinyl estradiol (EE) is effective in treating the symptoms of severe premenstrual syndrome (PMS).
NCT00161681 Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 2005-07-01 The purpose of this study is to determine whether LNG/EE is effective in the treatment of menstrual cycle related symptoms.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ETHINYL ESTRADIOL; LEVONORGESTREL

Condition Name

Condition Name for ETHINYL ESTRADIOL; LEVONORGESTREL
Intervention Trials
Contraception 14
Healthy 11
Drug Interactions 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ETHINYL ESTRADIOL; LEVONORGESTREL
Intervention Trials
Endometriosis 3
Premenstrual Syndrome 3
Sclerosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ETHINYL ESTRADIOL; LEVONORGESTREL

Trials by Country

Trials by Country for ETHINYL ESTRADIOL; LEVONORGESTREL
Location Trials
United States 126
China 12
Germany 11
Canada 6
Mexico 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ETHINYL ESTRADIOL; LEVONORGESTREL
Location Trials
Florida 12
California 8
Arizona 6
Texas 6
Washington 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ETHINYL ESTRADIOL; LEVONORGESTREL

Clinical Trial Phase

Clinical Trial Phase for ETHINYL ESTRADIOL; LEVONORGESTREL
Clinical Trial Phase Trials
Phase 4 8
Phase 3 17
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ETHINYL ESTRADIOL; LEVONORGESTREL
Clinical Trial Phase Trials
Completed 37
Recruiting 7
Not yet recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ETHINYL ESTRADIOL; LEVONORGESTREL

Sponsor Name

Sponsor Name for ETHINYL ESTRADIOL; LEVONORGESTREL
Sponsor Trials
Wyeth is now a wholly owned subsidiary of Pfizer 8
Bayer 5
Agile Therapeutics 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ETHINYL ESTRADIOL; LEVONORGESTREL
Sponsor Trials
Industry 47
Other 19
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
AstraZeneca
Merck
McKesson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.